Musaffa Logo
Biomind Labs Inc BMND.NE

Last Updated: Jul 21, 12:00 AM·NEO

BMND.NE Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Biomind Labs Inc is classified as halal.

HALAL

Report Source: 2025 Annual Report

Biomind Labs Inc

Biomind Labs Inc. Stock Analysis BMND.NE

Canada Health Care Nano Cap Report:
Biomind Labs, Inc. is a biotech research and development company focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is headquartered in Canelones, Ontario and currently employs 2 full-time employees. The company went IPO on 2021-07-27. The firm is focused on transforming biomedical sciences knowledge into novel pharmaceutical drugs and innovative nanotech delivery systems for a variety of psychiatric and neurological conditions. Through its acceleration platform, the Company is developing novel pharmaceutical formulations of the main psychedelic molecules, N, N-dimethyltryptamine (DMT), 5- MeO-DMT, and mescaline (collectively, the Molecules), for treating a wide range of therapeutic indications. DMT is a serotonergic psychedelic that exerts its effects through serotonergic receptors in the brain, including 5-HT2A, 5-HT1A, 5-HT2C and 5-HT7 receptors, among others. Under the 5-MeO-DMT Program, it is focused on two drug candidates: the BMND05: 5-MeO-DMT novel formulation indicated for Chronic Pain and the BMND08: 5-MeO-DMT novel formulation indicated for Alzheimer’s disease. Mescaline is a psychedelic alkaloid of the phenethylamine class.
Read More

Biomind Labs Inc (BMND.NE) Chart

Key Statistics of Biomind Labs Inc (BMND.NE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD0.03CAD0.04

Today's Open

CAD0.04

Volume

3300.00

P/E Ratio (TTM)

-

52 Week Range

CAD0.01CAD0.35

Market Cap

2.33M

Avg. Volume

2243.14

Dividend Yield

-

Financial Metrics & Statements of Biomind Labs Inc (BMND.NE)

Super Investors Invested in Biomind Labs Inc (BMND.NE)

FAQ's for Biomind Labs Inc (BMND.NE)

  • As of July 2026, Biomind Labs Inc BMND.NE is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Biomind Labs Inc using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Biomind Labs Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Biomind Labs Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Biomind Labs Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Biomind Labs Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.